FDANonrulemakingFDA-2026-N-0809

Who commented on this docket

Recommendations on Scale-Up and Postapproval Changes Guidances for Industry; Request for Comments.

3 organizations filed 4 public comments on Recommendations on Scale-Up and Postapproval Changes Guidances for Industry; Request for Comments., at the Food and Drug Administration. The comment window closed 15d ago.

Organizations
3
Comments
4
RIN
Comment window
closed 15d ago

Commenters (3)

View this docket on regulations.gov →

Attribution is name-based and imperfect. regulations.gov data is public record.